Evidence map›Paper›PMID 32620148›Full record

ArticleVirology journal2020

NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population.

Eric Nyarko, Christian Obirikorang, W K B A Owiredu, Evans Asamoah Adu, Emmanuel Acheampong, Freeman Aidoo, Emmanuel Ofori, Bright Selorm Addy, Henry Asare-Anane

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Hepatitis B and D virus entry.Nature reviews. Microbiology · 2025
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Eric NyarkoDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Christian ObirikorangDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. krisobiri@yahoo.com.
W K B A OwireduDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Evans Asamoah AduDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Emmanuel AcheampongDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Freeman AidooDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Emmanuel OforiDepartment of Molecular Medicine, School of Medicine and Dentistry|, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Bright Selorm AddySchool of Pharmacy, Central University, Accra, Ghana.
Henry Asare-AnaneDepartment of Chemical Pathology, University of Ghana Medical School, Accra, Ghana.
Kwame Nkrumah University of Science and Technology · GHCentral University · GHUniversity of Ghana · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSLC10A1 gene codes NTCP, a receptor through which the hepatitis B virus (HBV) gets access into hepatocytes - a stage of the viral cycle necessary for replication. Polymorphism variants of SLC10A1 play roles in HBV infection, viral clearance, treatment outcome, and complications, in diverse ethnic groups and countries. However, no such study has been conducted in the Ghanaian population, a country with HBV endemicity. Therefore, an exploratory study was conducted to investigate the presence of three (3) single nucleotide polymorphisms (SNPs) in the SLC10A1 gene (rs2296651, rs61745930, and rs4646287) and assessed the risk of HBV infection among the Ghanaian population.

methodPolymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used to determine the presence of the SNPs among 292 participants comprising 146 HBV infected persons as case-subjects and 146 HBV non-infected persons as control-subjects.

resultsThe minor allele frequency (T) of rs2296651 was present in a significantly high proportion of cases compared with the control group (11.6% vs. 3.1%, p < 0.0001). The homozygote recessive variant of rs61745930 was present in 2.7% of the control group and 5.5% of the case group. Moreover, the minor allele frequencies of rs4646287 were 9.3 and 8.2% among the control and the case group, respectively (p = 0.767). Under the dominant (CC) genetic model of inheritance, rs2296651 was found to be protective of HBV infection [OR = 0.18 (0.07-0.44)], whereas under the co-dominant and additive model, rs2296651 was a potential risk factor for HBV infection [OR = 5.2 (95%CI: 2.1-12.8); 3.5 (95%CI: 1.6-7.6], respectively. Variants of rs61745930 and rs4646287 were not associated with HBV infection (p > 0.05). Polymorphisms in SLC10A1, however, did not show any significant association with HBV infectivity (p > 0.05).

conclusionThe study highlights some polymorphism proof that variants rs2296651, rs61745930, and rs4646287 exist in HBV-infected individuals in Ghana. Although variant rs2296651 was found to be associated with HBV infection, this association warrants more studies. Polymorphisms in SLC10A1 were not associated with HBV infectivity among the Ghanaian population. Further investigation is warranted to assess the offensive role of the relationship between rs2296651 and HBV infectivity.

Indexed as

Polymorphism, Single NucleotideAdolescentAdultAgedCase-Control StudiesFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeGhanaHepatitis BHepatitis B virusHumansMaleMiddle AgedOrganic Anion Transporters, Sodium-Dependentsodium-bile acid cotransporterSymportersCHB infectionNTCPPCR-RFLPSLC10A1SNP

Identifiers

PMID32620148
PMCPMC7333392
OpenAlexW3039843406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.